Proskauer advised Atlas Venture on the deal. Atlas Venture, a leading early stage venture capital firm investing in groundbreaking biotech innovation, announced the closing of its thirteenth...
Atlas Venture’s $450 Million Fundraising
RA Capital Nexus Fund III’s $880 Million Fundraising
Proskauer advised RA Capital Management on the deal. RA Capital Management, LP, a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and...
Flagship Pioneering’s $3.4 Billion Fund VII Closing
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...
Perceptive Xontogeny Venture Fund II’s $515 Million Fundraising
Proskauer advised Perceptive Advisors on the deal. Perceptive Advisors completed the first and final closing of Perceptive Xontogeny Venture Fund II, LP (“PXV Fund II”) with $515...
Atlas Capital Resources IV’s $3.1 Billion Fundraising
Proskauer advised Atlas Holdings LLC on the deal. Atlas Holdings LLC completed the first and final close of its fourth private equity investment fund, Atlas Capital Resources...
RiverVest Venture Fund V’s $275 Million Fundraising
Proskauer advised RiverVest Venture Partners on the deal. RiverVest Venture Partners, a St. Louis-based venture capital firm, completed the closing of RiverVest Venture Fund V, L.P....
Bessemer Venture Partners’ $3.3 Billion Funds Formation
Proskauer advised Bessemer Venture Partners on the creation of two funds which, in total, raised $3.3 billion. The BVP XI fund, at $2.475 billion, will focus...